Correlation Between Innova Captab and Akums Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innova Captab and Akums Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innova Captab and Akums Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innova Captab Limited and Akums Drugs and, you can compare the effects of market volatilities on Innova Captab and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innova Captab with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innova Captab and Akums Drugs.

Diversification Opportunities for Innova Captab and Akums Drugs

-0.91
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Innova and Akums is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Innova Captab Limited and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and Innova Captab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innova Captab Limited are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of Innova Captab i.e., Innova Captab and Akums Drugs go up and down completely randomly.

Pair Corralation between Innova Captab and Akums Drugs

Assuming the 90 days trading horizon Innova Captab Limited is expected to generate 0.97 times more return on investment than Akums Drugs. However, Innova Captab Limited is 1.03 times less risky than Akums Drugs. It trades about 0.18 of its potential returns per unit of risk. Akums Drugs and is currently generating about -0.16 per unit of risk. If you would invest  75,180  in Innova Captab Limited on September 6, 2024 and sell it today you would earn a total of  27,305  from holding Innova Captab Limited or generate 36.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy98.41%
ValuesDaily Returns

Innova Captab Limited  vs.  Akums Drugs and

 Performance 
       Timeline  
Innova Captab Limited 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innova Captab Limited are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Innova Captab exhibited solid returns over the last few months and may actually be approaching a breakup point.
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Innova Captab and Akums Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innova Captab and Akums Drugs

The main advantage of trading using opposite Innova Captab and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innova Captab position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.
The idea behind Innova Captab Limited and Akums Drugs and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance